PMID: 7541236Jul 1, 1995Paper

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients

British Journal of Cancer
S J WigmoreK C Fearon

Abstract

The aim of this study was to investigate the effect of the cyclo-oxygenase inhibitor ibuprofen on the acute-phase protein response and resting energy expenditure (REE) of weight-losing patients with pancreatic cancer. Patients with irresectable pancreatic cancer (n = 16) were treated with either ibuprofen (1200 mg day-1 for 7 days (n = 10) or placebo (n = 6). A group of 17 age-related non-cancer subjects were also studied. Indirect calorimetry, anthropometry, multifrequency bioelectrical impedence analysis and serum C-reactive protein (CRP) estimation were performed immediately before and after treatment. Before treatment, total REE was significantly elevated in the pancreatic cancer patients compared with healthy controls (1499 +/- 71 vs 1377 +/- 58 kcal) (P < 0.02). Following treatment the mean REE of the ibuprofen group fell significantly (1386 +/- 89 kcal) compared with pretreatment values (1468 +/- 99 kcal) (P < 0.02), whereas no change was observed in the placebo group. Serum CRP concentration was also reduced in the ibuprofen-treated group (pre-ibuprofen, 51 mg l-1; post-ibuprofen, 29 mg l-1; P < 0.05). These results suggest that ibuprofen may have a role in abrogating the catabolic processes which contribute to weight l...Continue Reading

Citations

Dec 10, 1997·Journal of the National Cancer Institute·M J Tisdale
Apr 16, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·James A Ross, Kenneth C H Fearon
Dec 31, 2003·Current Treatment Options in Oncology·Leno ThomasMartin J Edelman
May 17, 2007·Scandinavian Journal of Gastroenterology·Bobby TingstedtRoland Andersson
Oct 18, 2012·Expert Opinion on Pharmacotherapy·Antonio MacciòGiovanni Mantovani
Dec 3, 2014·Cancer Biology & Therapy·Kara L KliewerMartha A Belury
Jul 3, 2015·Journal of Cachexia, Sarcopenia and Muscle·Rony DevEduardo Bruera
Mar 25, 2006·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Michael J Tisdale
Feb 27, 2003·The Oncologist·Francois G el-KamarPeter S Kozuch
Jun 25, 2003·Expert Review of Anticancer Therapy·Giovanni MantovaniElena Massa
Apr 28, 2001·Drugs·G MantovaniC Madeddu
May 25, 2002·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·Michelle N HarvieN Thatcher
Apr 9, 2002·Current Oncology Reports·Mellar P Davis
Apr 4, 2009·Physiological Reviews·Michael J Tisdale
Jun 2, 2004·International Journal of Cancer. Journal International Du Cancer·Guillermo D PeluffoSlobodanka M Klein
Jan 9, 2004·The Journal of Pharmacology and Experimental Therapeutics·Thomas W DavisJaime L Masferrer
Oct 11, 2005·QJM : Monthly Journal of the Association of Physicians·J N GordonP M Goggin
Jul 31, 2003·Biological Research for Nursing·Donna O McCarthy
Oct 26, 2012·Journal of Cachexia, Sarcopenia and Muscle·Vanessa C VaughanPaul A Lewandowski
Mar 19, 2014·Head & Neck·Marion E CouchHirak Der-Torossian
Dec 13, 2000·Surgical Oncology·M D BarberK C Fearon
Aug 7, 2002·International Journal of Cardiology·Kenneth C H Fearon, Alastair G W Moses

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.